News
14h
The Daily Galaxy on MSNNo, This Isn’t a Spider-Man Reboot—Scientists Just Made the World’s First Genetically Modified “Spider” That Spins Red Glowing SilkIn a quiet lab in Bayreuth, Germany, a team of researchers has achieved what has long eluded geneticists: modifying the ...
CRISPR Therapeutics has reported reductions in triglycerides and LDL cholesterol of more than 80% after a single dose of its in vivo liver editing prospect CTX310, encouraging the company to forge ...
Now, a first-in-human clinical trial is testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal cancers. The results show encouraging signs of safety ...
CRISPR Therapeutics stock is heavily shorted in the weeks going into earnings The short-sellers are betting against the name in a big way, with more than 20 million shares sold short as of the ...
At the upcoming annual meeting of the American Society of Gene and Cell Therapy, scientists from Huidagene Therapeutics will share an update on the development of their CRISPR-high-fidelity(hf ...
A few years ago, a British company called Genus set out to design pigs immune to this germ using CRISPR gene editing ... biohackers who say they’ll make glow-in-the-dark rabbits and have ...
CRISPR Therapeutics AG CRSP posted a loss for the first quarter on Tuesday. The company posted a quarterly loss of $1.58 per share, compared to market estimates of a loss of $1.21 per share.
acceptphoto via Shutterstock Who’s up for some CRISPR-y bacon? This week, the Food and Drug Administration approved gene-edited pigs developed by PIC, a biotechnology company specializing in ...
Prasad's social media reveals criticism of Verve's 1st-gen PCSK9 approach, which may signal negative sentiment for CRISPR to navigate. Unlock your all-in-one trading dashboard with real-time ...
The Board concluded that the Regents failed to conceive of the invention before the Broad’s reduction to practice on October 5, 2012, because their scientists lacked confidence that the CRISPR ...
Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results